F-Prime Capital — 2020 Investments

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsEIEight Roads VenturesGEGeneral AtlanticTOToba CapitalSESequoia Capital

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

WJWenbin Jiang, Ph.D.(CEO and Chairman of the Board; co-founder)Wenbin Jiang(Executive Officer, Director)inMYMing Yan, Ph.D.(Chief Technology Officer; co-founder)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E3E Bioventures CapitalNONorthern Light Venture CapitalRARA Capital

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

ALAndrew Le(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seatCBCarl Byers· per SEC Form D

Co-investorsEVEvolution VC PartnersTOTorch CapitalFUFundRxHUHumanaOPOptum VenturesTRTrustbridge Partners+1 more

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)inMatthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)inThomas W. Dubensky, Jr.(Executive Officer, Director)Thomas Woiwode(Director)Geoffrey Nichol(Director)

Board seatRWRobert Weisskoff· per SEC Form D

Co-investorsLALAVLILilly Asia VenturesNENew Enterprise Associates (NEA)QUQuan CapitalRORoche Venture FundVEVersant Ventures

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechToronto, US

David Qixiang Chen, PhD(Founder)inElvis Wianda(Founder)inLBLiran Belenzon(Founder)inTLTom Leung(Founder)inDavid Q. Chen(Founder)

Co-investorsINInovia CapitalGEGeneration Investment ManagementGRGradient VenturesTCTCV50500 GlobalAFAfore Capital+8 more

MarketMuse provides AI-powered content strategy and research tools for SEO and content teams, enabling them to analyze content inventories at scale, generate optimized briefs, and plan content strategy around user intent and search requirements.

AI & Machine LearningMarketing TechSaaS

ABAki BaloghinJCJeff Coyle(Co-Founder & Chief Revenue Officer)in

Co-investorsALAlpine MeridianCOColle Capital PartnersLALaunchCapitalLULunaCap VenturesRERevUp CapitalRIRiverside Acceleration Capital+4 more

Mozper is a fintech platform that provides physical and digital debit cards for children, along with financial literacy tools for parents to manage and monitor their children's spending across categories and teach money management.

ConsumerEdTechFintechMexico City, MX

GRGabriel Roizner(CEO)inYIYael Israeli(Founder)inPablo Klestorny

Co-investorsCACapria VenturesHEHetz VenturesIMImpacta Latam VCVEVentureSouqY Y CombinatorAMAmplifica Capital+9 more

Neo4j develops a graph database and graph data platform used to build applications that leverage connected data, with products including AuraDB, Graph Data Science, and vector search for GraphRAG and GenAI use cases.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSan Mateo, US

EEEmil Eifrem(Founder)inMichael Asher(Executive Officer)Johan Svensson(Founder)Peter Neubauer(Founder)

BoardLNLars Nordwall(Executive Officer)inMichael Treskow(Director)

Co-investorsGVGV (Google Ventures)INInovia CapitalCRCreandumEUEurazeoALAlanda Capital Holding LimitedDADawn Capital+7 more

Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.

BiotechHealthtechMedical DevicesSeattle, US

RMRichard Mulligan(Director)inHBHans Bishop(Founder)SHSteve Harr(Founder)JJJames J. MacDonald(Executive Officer)NHNathan Hardy(Executive Officer)

BoardGVGeoffrey von Maltzahn(Director)in

Co-investorsAMAmerican Family VenturesARARCH Venture PartnersCACatalytic Impact FoundationFLFlagship PioneeringGVGV (Google Ventures)INInnovating Capital+8 more

Spinwheel provides an API platform delivering real-time consumer credit data and embedded payments for lenders, personal finance managers, and debt management platforms.

AI & Machine LearningData & InfrastructureFintechFremont, US

TVTushar Vaish(Executive Officer, Director)inTCTomas Campos(Executive Officer, Director)inTCTomás Campos(Founder)in

PartnerDJDavid Jegen· led

Co-investorsCOCore Venture CapitalFIFikaFOFoundation CapitalQEQED InvestorsCICiti VenturesCOCore Innovation Capital+1 more

Tetraphase Pharmaceuticals was a Watertown, MA biopharmaceutical company developing novel tetracycline antibiotics, including its lead drug Xerava (eravacycline) for multidrug-resistant bacterial infections.

BiotechWatertown, US

Guy Macdonald(Director)inLarry Edwards(Executive Officer, Director)inMaria Stahl(Executive Officer)inChristopher Watt(Executive Officer)

BoardL. Patrick Gage(Director)Keith Maher(Director)

Co-investorsBABay City CapitalEXExcel Venture ManagementFLFlagship VenturesMEMediphase Venture Partners